Synovial Sarcoma of the Stomach: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 10 Cases

Only a few synovial sarcomas arising in the gastrointestinal tract have been reported, most of them are from the esophagus. We report clinical, histopathologic, and immunohistochemical features of 10 gastric synovial sarcomas. These tumors occurred in 4 males and 6 females with mean and median age of 52 years (range, 29 to 68 y). None of the patients had evidence of synovial sarcoma elsewhere. The tumor sizes ranged from 0.8 to 15 cm (mean, 3 cm). Two tumors were large transmural masses of 8 and 15 cm, and 8 were 0.8 to 6 cm, ulcerated cuplike or plaquelike or oval lesions predominantly involving the luminal side. Histologically, 9 tumors were monophasic one also having a poorly differentiated round cell component, and one was biphasic. Microscopic calcifications were present in 2 tumors. At least focal keratin (AE1/AE3 cocktail, keratin 7) and/or epithelial membrane antigen-positivity were detected in all tumors, and there was no CD34 or KIT-immunoreactivity. SYT-SSX fusion transcripts were demonstrated in 7 cases studied by a polymerase chain reaction-based fusion transcript assay. Five patients had a partial gastrectomy, and 5 underwent wedge or segmental resections. Two patients had received chemotherapy after surgery, but none had postoperative radiation. Four patients with plaquelike or cuplike tumors ≤3 cm were alive and well 1, 2, 2, and 18.5 years after surgery. Two patients died of tumor 25 and 29 months after surgery. One of them had a large 8-cm tumor, and another had a 2-cm tumor with a poorly differentiated component. Two patients were alive with recurrences 6 and 48 months after diagnosis. Synovial sarcoma rarely occurs as a gastric primary tumor. It has a variable prognosis depending on tumor size and differentiation, and should be considered in the differential diagnosis of KIT-negative gastric spindle cell neoplasms.

[1]  J. Lasota,et al.  Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. , 2009, Archives of pathology & laboratory medicine.

[2]  J. Lasota,et al.  Minute Synovial Sarcomas of the Hands and Feet: A Clinicopathologic Study of 21 Tumors Less Than 1 cm , 2006, The American journal of surgical pathology.

[3]  L. Sobin,et al.  A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential , 2004, Laboratory Investigation.

[4]  J. Fletcher,et al.  KIT-Negative Gastrointestinal Stromal Tumors: Proof of Concept and Therapeutic Implications , 2004, The American journal of surgical pathology.

[5]  S. Singer,et al.  Synovial Sarcoma: The Importance of Size and Location for Survival , 2004, Clinical orthopaedics and related research.

[6]  P. Casali,et al.  Expression of Ligand-Activated KIT and Platelet-Derived Growth Factor Receptor β Tyrosine Kinase Receptors in Synovial Sarcoma , 2004, Clinical Cancer Research.

[7]  L. Guillou,et al.  Monophasic Fibrous and Poorly Differentiated Synovial Sarcoma: Immunohistochemical Reassessment of 60 t(X;18)(SYT-SSX)-Positive Cases , 2002, The American journal of surgical pathology.

[8]  U. Lendahl,et al.  Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas * , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[9]  C. Fletcher,et al.  Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. , 2002, American journal of clinical pathology.

[10]  J. Taubenberger,et al.  Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction. , 2002, The Journal of molecular diagnostics : JMD.

[11]  J. Limon,et al.  Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas , 2000, Virchows Archiv.

[12]  L. Kindblom,et al.  Synovial sarcoma , 1999 .

[13]  A. Kovatich,et al.  CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[14]  J. Nesland,et al.  Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation. A study of 49 primary tumours, recurrences and metastases. , 1994, Pathology, research and practice.

[15]  Y. Oda,et al.  Survival in Synovial Sarcoma: A Multivariate Study of Prognostic Factors with Special Emphasis on the Comparison Between Early Death and Long-Term Survival , 1993, The American journal of surgical pathology.

[16]  S. Amr,et al.  Synovial sarcoma of the esophagus. , 1984, American journal of otolaryngology.

[17]  H. Shaw,et al.  Synovial sarcoma of the pharynx and oesophagus , 1983, The Journal of Laryngology & Otology.

[18]  E. Okamoto,et al.  Synovial sarcoma of the esophagus: Report of a case , 2010, Surgery Today.

[19]  Takatsugu Yamamoto,et al.  Synovial sarcoma metastatic to stomach and duodenum. , 2004, Gastrointestinal endoscopy.

[20]  O. Cummings,et al.  Synovial Sarcoma of the Upper Digestive Tract: A Report of Two Cases with Demonstration of the X;18 Translocation by Fluorescence In Situ Hybridization , 2000, Modern Pathology.

[21]  L. Edmunds,et al.  Polypoid synovial sarcoma of the esophagus. , 1987, Gastroenterology.